Goho.Ta
GOHO.TA operates in the healthcare sector, providing pharmaceutical products and services, primarily generating revenue through the sale of pharmaceuticals and related healthcare services.
Business. GOHO.TA operates in the healthcare sector, providing pharmaceutical products and services, primarily generating revenue through the sale of pharmaceuticals and related healthcare services.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GOHO.TA operates in the healthcare sector, providing pharmaceutical products and services, primarily generating revenue through the sale of pharmaceuticals and related healthcare services.
GOHO.TA maintains a strong liquidity position, with cash and equivalents amounting to ILS 81.77 million, representing 19.77% of total assets. The company's liquidity FPT (free cash flow to total assets) is negative at -47.05%, indicating a significant outflow of cash relative to asset base. The current ratio of 1.16 suggests the company has sufficient short-term assets to cover its short-term liabilities, though not with a large margin of safety.
Profitability metrics for GOHO.TA are mixed. The company's return on equity (ROE) is 2.68%, and return on assets (ROA) is 1.78%, both below the typical thresholds for high-performing healthcare firms. The price-to-earnings (P/E) ratio of 2293.22 and price-to-book (P/B) ratio of 61.55 suggest the stock is highly valued relative to earnings and book value, which may reflect investor expectations of future growth or market sentiment.
The company's revenue is concentrated in the pharmaceuticals segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to specific market risks, such as regulatory changes or shifts in demand for pharmaceutical products.
Looking ahead, GOHO.TA's growth trajectory is uncertain. The company's free cash flow is negative at ILS -192.20 million, and capital expenditures are ILS -5.25 million, indicating ongoing investment in operations. However, the lack of disclosed revenue growth rates or segment-specific growth projections makes it difficult to assess the company's future performance.
Risk factors for GOHO.TA include liquidity and dilution risks, both of which are currently rated as low. The company has no immediate filing-based liquidity or dilution flags, and the dilution potential is minimal given the equal number of basic and diluted shares outstanding.
Recent events and filings for GOHO.TA do not indicate any significant changes in the company's operations or financial position. The absence of recent earnings calls or regulatory filings suggests a stable but uneventful period for the company.
- GOHO.TA has a strong liquidity position with significant cash reserves but a negative free cash flow to total assets ratio.
- The company's profitability metrics are below industry norms, and its stock is highly valued relative to earnings and book value.
- Revenue is concentrated in the pharmaceuticals segment, with no disclosed geographic diversification.
- Growth trajectory is uncertain due to negative free cash flow and lack of detailed growth projections.
- Liquidity and dilution risks are currently low, with no immediate filing-based flags.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- GOHO.TA Market data — financials · 2026-05-28